Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$5.83M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$799K$1.6M2025 · bought $0 · sold $1.6M20252026 · bought $0 · sold $391K2026
Total +$0.0000 bought · $1.99M sold

All filings on record

Every Form 4 transaction we track for this filer

BCAXSell
2026-05-15 · Bicara Therapeutics Inc.
$91.3K
BCAXSell
2026-05-15 · Bicara Therapeutics Inc.
$162.3K
BCAXExercise
2026-05-15 · Bicara Therapeutics Inc.
$30.3K
BCAXSell
2026-02-25 · Bicara Therapeutics Inc.
$9.4K
BCAXSell
2026-02-25 · Bicara Therapeutics Inc.
$56.1K
BCAXExercise
2026-02-25 · Bicara Therapeutics Inc.
$11.8K
BCAXSell
2026-01-22 · Bicara Therapeutics Inc.
$69.3K
BCAXSell
2026-01-15 · Bicara Therapeutics Inc.
$2.7K
BCAXExercise
2025-12-26 · Bicara Therapeutics Inc.
$110.9K
BCAXSell
2025-12-15 · Bicara Therapeutics Inc.
$84.1K
BCAXSell
2025-12-15 · Bicara Therapeutics Inc.
$149.5K
BCAXExercise
2025-12-15 · Bicara Therapeutics Inc.
$30.3K
BCAXSell
2025-11-21 · Bicara Therapeutics Inc.
$81.2K
BCAXSell
2025-11-21 · Bicara Therapeutics Inc.
$144.4K
BCAXExercise
2025-11-21 · Bicara Therapeutics Inc.
$30.3K
BCAXSell
2025-10-15 · Bicara Therapeutics Inc.
$81.7K
BCAXSell
2025-10-15 · Bicara Therapeutics Inc.
$145.2K
BCAXExercise
2025-10-15 · Bicara Therapeutics Inc.
$30.3K
BCAXSell
2025-10-07 · Bicara Therapeutics Inc.
$52.4K
BCAXSell
2025-10-07 · Bicara Therapeutics Inc.
$144.5K
BCAXExercise
2025-10-07 · Bicara Therapeutics Inc.
$30.3K
BCAXSell
2025-10-06 · Bicara Therapeutics Inc.
$281.7K
BCAXSell
2025-10-06 · Bicara Therapeutics Inc.
$433.3K
BCAXExercise
2025-10-06 · Bicara Therapeutics Inc.
$91.0K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.